| The cell biology of Listeria monocytogenes infection: the intersection of bacterial pathogenesis and cell-mediated immunity DA Portnoy, V Auerbuch, IJ Glomski The Journal of cell biology 158 (3), 409, 2002 | 573 | 2002 |
| Mice lacking the type I interferon receptor are resistant to Listeria monocytogenes V Auerbuch, DG Brockstedt, N Meyer-Morse, M O'Riordan, DA Portnoy The Journal of experimental medicine 200 (4), 527, 2004 | 558 | 2004 |
| Pivotal role of VASP in Arp2/3 complex–mediated actin nucleation, actin branch-formation, and Listeria monocytogenes motility J Skoble, V Auerbuch, ED Goley, MD Welch, DA Portnoy The Journal of cell biology 155 (1), 89, 2001 | 194 | 2001 |
| Bacterial ligands generated in a phagosome are targets of the cytosolic innate immune system AA Herskovits, V Auerbuch, DA Portnoy PLoS pathogens 3 (3), e51, 2007 | 192 | 2007 |
| Chemical inhibitors of the type three secretion system: disarming bacterial pathogens MC Duncan, RG Linington, V Auerbuch Antimicrobial agents and chemotherapy 56 (11), 5433-5441, 2012 | 138 | 2012 |
| Innate Immune Recognition of Yersinia pseudotuberculosis Type III Secretion V Auerbuch, DT Golenbock, RR Isberg PLoS pathogens 5 (12), e1000686, 2009 | 115 | 2009 |
| Development of a Competitive Index Assay To Evaluate the Virulence of Listeria monocytogenes actAMutants during Primary and Secondary Infection of Mice V Auerbuch, LL Lenz, DA Portnoy Infection and immunity 69 (9), 5953-5957, 2001 | 103 | 2001 |
| Ena/VASP proteins contribute to Listeria monocytogenes pathogenesis by controlling temporal and spatial persistence of bacterial actin‐based motility V Auerbuch, JJ Loureiro, FB Gertler, JA Theriot, DA Portnoy Molecular microbiology 49 (5), 1361-1375, 2003 | 95 | 2003 |
| IscR Is Essential for Yersinia pseudotuberculosis Type III Secretion and Virulence HK Miller, L Kwuan, L Schwiesow, DL Bernick, E Mettert, HA Ramirez, ... PLoS pathogens 10 (6), e1004194, 2014 | 74 | 2014 |
| Yersinia type III secretion system master regulator LcrF L Schwiesow, H Lam, P Dersch, V Auerbuch Journal of Bacteriology 198 (4), 604-614, 2016 | 57 | 2016 |
| Growth of Yersinia pseudotuberculosis in Mice Occurs Independently of Toll-Like Receptor 2 Expression and Induction of Interleukin-10 V Auerbuch, RR Isberg Infection and immunity 75 (7), 3561-3570, 2007 | 50 | 2007 |
| Bacterial iron–sulfur cluster sensors in mammalian pathogens HK Miller, V Auerbuch Metallomics 7 (6), 943-956, 2015 | 49 | 2015 |
| Impact of host membrane pore formation by the Yersinia pseudotuberculosis type III secretion system on the macrophage innate immune response L Kwuan, W Adams, V Auerbuch Infection and immunity 81 (3), 905-914, 2013 | 49 | 2013 |
| Analysis of Genes Encoding an Alternative Nitrogenase in the Archaeon Methanosarcina barkeri227 YT Chien, V Auerbuch, AD Brabban, SH Zinder Journal of bacteriology 182 (11), 3247-3253, 2000 | 48 | 2000 |
| An NF-κB-based high-throughput screen identifies piericidins as inhibitors of the Yersinia pseudotuberculosis type III secretion system MC Duncan, WR Wong, AJ Dupzyk, WM Bray, RG Linington, V Auerbuch Antimicrobial agents and chemotherapy 58 (2), 1118-1126, 2014 | 40 | 2014 |
| Stability of the Listeria monocytogenes ActA protein in mammalian cells is regulated by the N‐end rule pathway MA Moors, V Auerbuch, DA Portnoy Cellular microbiology 1 (3), 249-257, 1999 | 35 | 1999 |
| Control of hmu Heme Uptake Genes in Yersinia pseudotuberculosis in Response to Iron Sources L Schwiesow, E Mettert, Y Wei, HK Miller, NG Herrera, D Balderas, ... Frontiers in Cellular and Infection Microbiology 8, 47, 2018 | 30 | 2018 |
| Hereditary Hemochromatosis Predisposes Mice to Yersinia pseudotuberculosis Infection Even in the Absence of the Type III Secretion System HK Miller, L Schwiesow, W Au-Yeung, V Auerbuch Frontiers in Cellular and Infection Microbiology 6, 69, 2016 | 24 | 2016 |
| The Yersinia Type III Secretion System as a Tool for Studying Cytosolic Innate Immune Surveillance KA Schubert, Y Xu, F Shao, V Auerbuch Annual Review of Microbiology 74 (1), 221-245, 2020 | 19 | 2020 |
| Synthetic cyclic peptomers as type III secretion system inhibitors H Lam, J Schwochert, Y Lao, T Lau, C Lloyd, J Luu, O Kooner, J Morgan, ... Antimicrobial agents and chemotherapy 61 (9), 10.1128/aac. 00060-17, 2017 | 19 | 2017 |
